E-LIB Suche - Ergebnisse für: Nomiyama, Takashi

1

A simple questionnaire for the detection of testosterone de..:

Akehi, Yuko ; Tanabe, Makito ; Yano, Hiromi...
Endocrine Journal. 69 (2022) 11 - p. 1303-1312 , 2022

2

Differential Effects of DPP-4 Inhibitors, Anagliptin and Si..:

Furuhashi, Masato ; Sakuma, Ichiro ; Morimoto, Takeshi...
Journal of Atherosclerosis and Thrombosis. 29 (2022) 1 - p. 24-37 , 2022

Link: https://doi.org/10.5551/..

3

Effect of Anagliptin versus Sitagliptin on Renal Function: ..:

Teragawa, Hiroki ; Morimoto, Takeshi ; Fujii, Yuichi...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 15 (2022) - p. 685-694 , 2022

Link: https://doi.org/10.2147/..

4

Combined treatment with glucagon-like peptide-1 receptor ag..:

Tanaka, Yuki ; Iwaya, Chikayo ; Kawanami, Takako...
Diabetology International. 13 (2021) 3 - p. 480-492 , 2021

Link: https://doi.org/10.1007/..

5

Sodium-glucose cotransporter 2 inhibitor canagliflozin atte..:

Yamamoto, Leona ; Yamashita, Shinichi ; Nomiyama, Takashi...
Diabetology International. 12 (2021) 4 - p. 389-398 , 2021

Link: https://doi.org/10.1007/..

6

Pemafibrate, a PPAR alpha agonist, attenuates neointima for..:

Horikawa, Tsuyoshi ; Kawanami, Takako ; Hamaguchi, Yuriko...
Heliyon. 6 (2020) 11 - p. e05431 , 2020

Link: https://doi.org/10.1016/..

7

Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascul..:

Nomiyama, Takashi
Journal of Atherosclerosis and Thrombosis. 27 (2020) 11 - p. 1139-1140 , 2020

Link: https://doi.org/10.5551/..

8

Efficacy and safety of a combination of an insulin secretag..:

Collaborators in the Repaglinide Glucose Oscillation Study in Fukuoka (REGO-F) trial ; Terawaki, Yuichi ; Iwaya, Chikayo...
Diabetology International. 11 (2020) 3 - p. 274-282 , 2020

Link: https://doi.org/10.1007/..

9

Effect of Anagliptin versus Sitagliptin on Inflammatory Mar..:

Teragawa, Hiroki ; Morimoto, Takeshi ; Fujii, Yuichi...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 13 (2020) - p. 4993-5001 , 2020

Link: https://doi.org/10.2147/..

10

Independent and Distinct Associations of FABP4 and FABP5 Wi..:

Furuhashi, Masato ; Sakuma, Ichiro ; Morimoto, Takeshi...
Frontiers in Endocrinology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

11

SGLT2 inhibitor ipragliflozin attenuates breast cancer cell..:

Komatsu, Shiho ; Nomiyama, Takashi ; Numata, Tomohiro...
Endocrine Journal. 67 (2020) 1 - p. 99-106 , 2020

Link: https://doi.org/10.1507/..

12

Treatment with anagliptin, a DPP-4 inhibitor, decreases FAB..:

Furuhashi, Masato ; Sakuma, Ichiro ; Morimoto, Takeshi...
Cardiovascular Diabetology. 19 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

13

Author Correction: Randomized Evaluation of Anagliptin vs S..:

Morimoto, Takeshi ; Sakuma, Ichiro ; Sakuma, Mio...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

14

Relatively low sex hormone‐binding globulin concentration i..:

Fujihara, Yuya ; Hamanoue, Nobuya ; Akehi, Yuko...
Obesity Science & Practice. 6 (2020) 4 - p. 425-433 , 2020

Link: https://doi.org/10.1002/..

15

Activation of overexpressed glucagon‐like peptide‐1 recepto..:

Shigeoka, Toru ; Nomiyama, Takashi ; Kawanami, Takako...
Journal of Diabetes Investigation. 11 (2020) 5 - p. 1137-1149 , 2020

Link: https://doi.org/10.1111/..